Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection Written By Dr. Kamal Kant Kohli19 May 2022 12:54 PM ISTThe spiking frequency of allergic respiratory illness over the last several decades, and the increasing rate of air pollution owing to urbanization,...
Combatting allergic rhinitis-Why prefer Fexofenadine - Montelukast over Bilastine-Montelukast? Written By dr. Abhimanyu Uppal9 Nov 2021 12:31 PM ISTWith the COVID restrictions getting unlocked in almost all states of India along with the approaching season of allergies, physicians across the...
Physician's choice of antihistaminic-leukotriene antagonist combination: An evidence-based comparison of montelukast-fexofenadine versus montelukast- levocetirizine Written By dr. Abhimanyu Uppal8 Sept 2021 12:12 PM ISTNew Delhi: The pandemic restrictions are unlocking amid the looming fear of a 3rd COVID wave at this year's end. Physicians need to be aware and...
New updates in COVID-19 research: Emerging therapeutic role of Fexofenadine and Montelukast. Written By dr. Abhimanyu Uppal10 July 2021 11:17 AM ISTThe dawn of the year 2020 witnessed the surge of one of the biggest pandemics known to mankind. COVID-19 spread through continents affecting millions...
Ind-Swift Labs launches anti-allergic drug Fexofenadine in US Ruchika Sharma17 Jun 2020 2:49 PM ISTFexofenadine is an AntiHistamine Drug used for the treatment of seasonal allergic rhinitis and Urticaria in US market.
Antenatal Fexofenadine not linked to risk of abortion or premature birth Written By Dr. Kamal Kant Kohli4 Jun 2020 4:41 PM ISTA new JAMA study has revealed that Fexofenadine use during pregnancy was not linked with birth defects or spontaneous abortion. Antihistamines are one...
